Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Williams

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Blood|June 12, 2004
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcomeNeal Flomenberg, Lee Ann Baxter-Lowe, Dennis Confer, et al.
Genome Biology|September 19, 2025
A compendium of synthetic lethal gene pairs defined by extensive combinatorial pan-cancer CRISPR screeningVictoria Harle, Victoria Offord, Birkan Gökbağ, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 2023
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective TreatmentsNevin A John, Bhavana S Solanky, Floriana De Angelis, et al.
European Journal of Neurology|June 15, 2023
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
Neuroimage. Reports|September 27, 2024
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
Plos One|April 13, 2023
The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysisDavid J Pascall, Elen Vink, Rachel Blacow, et al.
The Journal of Infection|June 3, 2023
Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistentDavid J Pascall, Elen Vink, Rachel Blacow, et al.
The National Catholic Bioethics Quarterly|January 24, 2006
Production of pluripotent stem cells by oocyte-assisted reprogramming: joint statement with signatoriesHadley Arkes, Nicanor Pier Giorgio Austriaco, Thomas Berg, et al.
The European Respiratory Journal|March 15, 2023
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVIDNicholas A Scott, Laurence Pearmain, Sean B Knight, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Blood|June 12, 2004
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcomeNeal Flomenberg, Lee Ann Baxter-Lowe, Dennis Confer, et al.
Genome Biology|September 19, 2025
A compendium of synthetic lethal gene pairs defined by extensive combinatorial pan-cancer CRISPR screeningVictoria Harle, Victoria Offord, Birkan Gökbağ, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 2023
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective TreatmentsNevin A John, Bhavana S Solanky, Floriana De Angelis, et al.
European Journal of Neurology|June 15, 2023
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
Neuroimage. Reports|September 27, 2024
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
Plos One|April 13, 2023
The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysisDavid J Pascall, Elen Vink, Rachel Blacow, et al.
The Journal of Infection|June 3, 2023
Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistentDavid J Pascall, Elen Vink, Rachel Blacow, et al.
The National Catholic Bioethics Quarterly|January 24, 2006
Production of pluripotent stem cells by oocyte-assisted reprogramming: joint statement with signatoriesHadley Arkes, Nicanor Pier Giorgio Austriaco, Thomas Berg, et al.
The European Respiratory Journal|March 15, 2023
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVIDNicholas A Scott, Laurence Pearmain, Sean B Knight, et al.
Pageof 15